Where does Merit Medical Systems's cash flow data come from?

Every line is extracted from Merit Medical Systems's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	$139.34M+14.0%	$128.49M+6.8%	$118.43M-1.3%	$119.12M+1.4%	$122.26M+19.9%
Depreciation and amortization	$124.37M+14.7%	$123.17M+19.9%	$120.25M+23.1%	$115.33M+20.9%	$108.4M+16.5%
Stock-based compensation	$43.34M+34.1%	$43.46M+52.6%	$43.08M+72.7%	$36.18M+50.6%	$32.32M+43.0%
Amortization of debt issuance costs	——	——	——	——	——
Impairment charges	$418K+46.2%	$313K-31.4%	$207K-53.6%	$258K-43.7%	$286K—
Gain (loss) on sale of assets	-$2.28M-48.0%	-$2.3M-54.5%	-$1.82M-40.9%	-$1.73M-39.2%	-$1.54M+72.8%
Change in accounts receivable	——	——	——	——	$17.06M—
Change in inventories	$33.66M—	$21.6M—	——	——	——
Change in accounts payable	——	——	——	——	——
Change in accrued liabilities	$1.74M—	$14.26M—	$15.18M—	——	——
Change in other assets	——	——	——	——	——
Change in other liabilities	——	——	——	——	——
Other working capital changes	$158.14M+53.7%	$168.88M+68.1%	$149.18M+58.2%	$120.84M+20.1%	$102.89M+58.6%
Change in income taxes payable/receivable	$11.15M—	$5.61M—	——	——	——
Net gains (losses) on investments	——	——	——	——	——
Non-cash operating lease expense	$11.35M-4.5%	$11.48M-4.5%	$11.67M-0.5%	$11.73M+2.5%	$11.89M+1.0%
Change in operating lease liabilities	-$10.6M+15.8%	-$11.17M+8.3%	-$11.71M+2.3%	-$12.15M-3.4%	-$12.59M-3.3%
Change in fair value of contingent consideration	——	——	$1.35M—	$1.42M—	$1.58M—
Change in receivables	——	——	——	$3.17M+320%	$6.27M+297%
Net cash from operating activities	$297.48M+32.1%	$297.37M+34.7%	$267.61M+24.9%	$239.96M+10.1%	$225.16M+35.0%
Capital expenditures	$76.66M+72.2%	$81.72M+133%	$60.72M+56.5%	$47.64M+25.2%	$44.52M+34.1%
Acquisitions, net of cash acquired	$144.77M-54.5%	$144.77M-54.8%	$332.83M—	$437.81M—	$318.18M—
Proceeds from sale of businesses	——	——	——	——	——
Purchases of intangible assets	$3.42M+36.9%	$3.12M+7.5%	$3.09M+10.7%	$2.62M-10.8%	$2.5M-16.7%
Net cash from investing activities	-$210.02M+44.2%	-$247.39M+32.9%	-$411.5M-153%	-$503.1M-796%	-$376.24M-106%
Proceeds from issuance of debt	——	——	——	——	——
Proceeds from issuance of common stock	$17.84M-61.5%	$28.21M-31.0%	$47.66M+144%	$49.99M+193%	$46.33M+140%
Other financing activities	$4.78M+1,932%	$2.69M+929%	$2.7M+877%	$2.69M+870%	$235K-78.2%
Net cash from financing activities	$3.12M—	$16.36M—	——	——	——
Effect of exchange rate changes on cash	$2.44M+1,037%	$3.8M+251%	-$192K—	$2.19M—	-$260K—
Net increase (decrease) in cash	$92.65M+150%	$69.78M+133%	-$130.72M-128%	-$294.8M-151%	-$186.39M-135%
Interest paid	——	——	$28.16M+10.6%	$32.37M+119%	$33.21M+130%
Income taxes paid	$31.99M-31.6%	$31.39M-30.3%	$35.32M-11.1%	$42.09M+15.7%	$46.77M+50.2%
Non-cash interest expense	——	——	——	——	——
Contingent consideration fair value adjustments	——	——	$1.35M—	$1.42M—	$1.58M—
Gain/(loss) on dispositions, net	-$2.28M-48.0%	-$2.3M-54.5%	-$1.82M-40.9%	-$1.73M-39.2%	-$1.54M+72.8%
Gain on sale of business and assets	$12.69M—	$249K—	——	——	——
Equity in earnings (losses) of equity method investees	——	——	——	——	——
Accounts payable	——	——	——	——	——
Increase Decrease In Deferred Compensation	——	——	-$2.11M-157%	$1.23M—	$410K—
Increase (Decrease) in Income Taxes Receivable	$1.71M—	-$246K—	——	——	——
Operating lease liabilities	-$10.6M+15.8%	-$11.17M+8.3%	-$11.71M+2.3%	-$12.15M-3.4%	-$12.59M-3.3%
Increase (Decrease) in Other Operating Assets	$2.38M-27.9%	$1.83M-69.8%	$4.04M-55.7%	$4.57M—	$3.3M—
Increase (Decrease) in Other Receivables	——	——	——	$3.17M+320%	$6.27M+297%
Increase (Decrease) in Prepaid Expense and Other Assets	——	——	——	——	——
Operating lease right-of-use asset amortization	$11.35M-4.5%	$11.48M-4.5%	$11.67M-0.5%	$11.73M+2.5%	$11.89M+1.0%
Payments to Acquire Intangible Assets	$3.42M+36.9%	$3.12M+7.5%	$3.09M+10.7%	$2.62M-10.8%	$2.5M-16.7%
Proceeds From Sale Of Property Plant And Equipment And Divestiture Of Businesses	——	$303K+5,960%	$228.5K+41.3%	$154K-51.6%	$79.5K-83.3%
Payments For Derivative Instrument Financing Activities	——	——	——	——	——
Payments Related To Tax Withholding For Exchange Of Common Stock	$10.31M—	$9.53M—	——	——	——
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations	$2.44M+1,037%	$3.8M+251%	-$192K—	$2.19M—	-$260K—
Leased assets obtained in exchange for operating lease liabilities	$9.6M-64.5%	$32.68M+229%	$31.51M+199%	$30.28M+122%	$27.06M+63.4%
Income Taxes Paid, Net	$31.99M-31.6%	$31.39M-30.3%	$35.32M-11.1%	$42.09M+15.7%	$46.77M+50.2%
Free cash flow	$220.82M+22.2%	$215.66M+16.2%	$206.88M+17.9%	$192.31M+6.8%	$180.64M+35.2%
Free cash flow	$220.82M+22.2%	$215.66M+16.2%	$206.88M+17.9%	$192.31M+6.8%	$180.64M+35.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Merit Medical Systems's cash flow data come from?: Every line is extracted from Merit Medical Systems's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.